Abstract
Obesity hypoventilation syndrome (OHS) has become a common cause of chronic hypercapnic respiratory failure and is now the leading indication for home nocturnal noninvasive positive pressure ventilation (NPPV) in many countries. The presence of this disorder is often overlooked despite these individuals having frequent contact with health care services several years prior to the diagnosis being made. Once on effective therapy, significant improvements in awake gas exchange, symptoms, and quality of life can be achieved. Although nocturnal positive airway pressure (PAP) therapy is widely used, the most appropriate mode of therapy to manage this condition has yet to be determined. Even when adherence to therapy is high, complete correction of awake hypercapnic respiratory failure may not occur in some patients, highlighting that sleep-disordered breathing (SDB) is not the only factor contributing to underbreathing in OHS. In addition to nocturnal PAP therapy, strategies to promote weight loss and reduce sedentary behavior are crucial to minimize the substantial health and social impacts of this increasingly prevalent condition.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
World Health Organisation. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. WHO Technical Report Series. 2000:894.
Finucane MM, Stevens GA, Cowan MJ, et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants. Lancet. 2011;377(9765):557–67.
World Health Organisation. Obesity and overweight, Factsheet No 311. http://www.who.int/mediacentre/factsheets/fs311/en/index.html. 2013; Accessed 31 March 2013.
Trayhurn P. Hypoxia and adipose tissue function and dysfunction in obesity. Physiol Rev. 2013;93(1):1–21.
Whitlock G, Lewington S, Sherliker P, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373(9669):1083–96.
Sturm R. Increases in morbid obesity in the USA: 2000–2005. Public Health. 2007;121(7):492–6.
Snih S A, Ottenbacher KJ, Markides KS, Kuo YF, Eschbach K, Goodwin JS. The effect of obesity on disability vs mortality in older Americans. Arch Intern Med. 2007;167(8):774–80.
Koebnick C, Smith N, Huang K, Martinez MP, Clancy HA, Kushi LH. The prevalence of obesity and obesity-related health conditions in a large, multiethnic cohort of young adults in California. Ann Epidemiol. 2012;22(9):609–16.
Olson A, Zwillich C. The obesity hypoventilation syndrome. Am J Med. 2005;118:948–56.
Akashiba T, Akahoshi T, Kawahara S, et al. Clinical characteristics of obesity-hypoventilation syndrome in Japan: a multi-center study. Intern Med. 2006;45(20):1121–5.
Kessler R, Chaouat A, Schinkewitch P, et al. The obesity-hypoventilation syndrome revisited: a prospective study of 34 consecutive cases. Chest. 2001;120(2):369–76.
Budweiser S, Riedl SG, Jorres RA, Heinemann F, Pfeifer M. Mortality and prognostic factors in patients with obesity-hypoventilation syndrome undergoing noninvasive ventilation. J Intern Med. 2007;261(4):375–83.
Trakada GP, Steiropoulos P, Nena E, Constandinidis TC, Bouros D. Prevalence and clinical characteristics of obesity hypoventilation syndrome among individuals reporting sleep-related breathing symptoms in northern Greece. Sleep Breath. 2010;14(4):381–6.
Garner DJ, Berlowitz DJ, Douglas J, et al. Home mechanical ventilation in Australia and New Zealand. Eur Respir J. 2013;41(1):39–45.
Janssens JP, Derivaz S, Breitenstein E, et al. Changing patterns in long-term noninvasive ventilation: a 7-year prospective study in the Geneva Lake area. Chest. 2003;123(1):67–79.
Lloyd-Owen SJ, Donaldson GC, Ambrosino N, et al. Patterns of home mechanical ventilation use in Europe: results from the Eurovent survey. Eur Respir J. 2005;25(6):1025–31.
Mokhlesi B, Saager L, Kaw R. Q: Should we routinely screen for hypercapnia in sleep apnea patients before elective noncardiac surgery? Cleve Clin J Med. 2010;77(1):60–1.
Mokhlesi B, Tulaimat A. Recent advances in obesity hypoventilation syndrome. Chest. 2007;132(4):1322–36.
Kawata N, Tatsumi K, Terada J, et al. Daytime hypercapnia in obstructive sleep apnea syndrome. Chest. 2007;132(6):1832–8.
Laaban J-P, Chailleux E. For the Observatory Group of ANTADIR. Daytime hypercapnia in adult patients with obstructive sleep apnea syndrome in France, before initiating nocturnal nasal continuous positive airway pressure therapy. Chest. 2005;127(3):710–5.
Mokhlesi B, Tulaimat A, Faibussowitsch I, Wang Y, Evans A. Obesity hypoventilation syndrome: prevalence and predictors in patients with obstructive sleep apnea. Sleep Breath. 2007;11(2):117–24.
Resta O, Foschino Barbaro MP, Bonfitto P, et al. Hypercapnia in obstructive sleep apnoea syndrome. Neth J Med. 2000;56(6):215–22.
Verin E, Tardif C, Pasquis P. Prevalence of daytime hypercapnia or hypoxia in patients with OSAS and normal lung function. Respir Med. 2001;95(8):693–6.
Chau EH, Lam D, Wong J, Mokhlesi B, Chung F. Obesity hypoventilation syndrome: a review of epidemiology, pathophysiology, and perioperative considerations. Anesthesiology. 2012;117(1):188–205.
Nowbar S, Burkart KM, Gonzales R, et al. Obesity-associated hypoventilation in hospitalized patients: prevalence, effects, and outcome. Am J Med. 2004;116(1):1–7.
Berg G, Delaive K, Manfreda J, Walld R, Kryger MH. The use of health-care resources in obesity-hypoventilation syndrome. Chest. 2001;120(2):377–83.
Jennum P, Ibsen R, Kjellberg J. Morbidity prior to a diagnosis of sleep-disordered breathing: a controlled national study. J Clin Sleep Med. 2013;9(2):103–8.
Borel J-C, Roux-Lombard P, Tamisier R, et al. Endothelial dysfunction and specific inflammation in obesity hypoventilation syndrome. PLoS ONE. 2009;4(8):e6733.
Priou P, Hamel J-F, Person C, et al. Long-term outcome of noninvasive positive pressure ventilation for obesity hypoventilation syndrome. Chest. 2010;138(1):84–90.
Jennum P, Kjellberg J. Health, social and economical consequences of sleep-disordered breathing: a controlled national study. Thorax. 2011;66(7):560–6.
Jennum P, Ibsen R, Kjellberg J. Social consequences of sleep disordered breathing on patients and their partners. A controlled national study. Eur Respir J. 2013.
Berg KM, Lang GR, Salciccioli JD, et al. The rapid shallow breathing index as a predictor of failure of noninvasive ventilation for patients with acute respiratory failure. Respir Care. 2012;57(10):1548–54.
Carrillo A, Ferrer M, Gonzalez-Diaz G, et al. Noninvasive ventilation in acute hypercapnic respiratory failure caused by obesity hypoventilation syndrome and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186(12):1279–85.
Marik PE, Desai H. Characteristics of patients with the “malignant obesity hypoventilation syndrome” admitted to an ICU. J Intensive Care Med. 2013;28(2):124–30.
Quint JK, Ward L, Davison AG. Previously undiagnosed obesity hypoventilation syndrome. Thorax. 2007;62(5):462–3.
Akashiba T, Kawahara S, Kosaka N, et al. Determinants of chronic hypercapnia in Japanese men with obstructive sleep apnea syndrome. Chest. 2002;121(2):415–21.
Kaw R, Hernandez AV, Walker E, Aboussouan L, Mokhlesi B. Determinants of hypercapnia in obese patients with obstructive sleep apnea: a systematic review and metaanalysis of cohort studies. Chest. 2009;136(3):787–96.
Pelosi P, Croci M, Ravagnan I, et al. Respiratory system mechanics in sedated, paralyzed, morbidly obese patients. J Appl Physiol. 1997;82(3):811–8.
Watson RA, Pride NB. Postural changes in lung volumes and respiratory resistance in subjects with obesity. J Appl Physiol. 2005;98(2):512–7.
Piper AJ, Grunstein RR. Big breathing: the complex interaction of obesity, hypoventilation, weight loss, and respiratory function. J Appl Physiol. 2010;108(1):199–205.
Lin CC, Wu KM, Chou CS, Liaw SF. Oral airway resistance during wakefulness in eucapnic and hypercapnic sleep apnea syndrome. Respir Physiol Neurobiol. 2004;139(2):215–24.
Lee MY, Lin CC, Shen SY, Chiu CH, Liaw SF. Work of breathing in eucapnic and hypercapnic sleep apnea syndrome. Respiration. 2009;77(2):146–53.
Pankow W, Hijjeh N, Schuttler F, et al. Influence of noninvasive positive pressure ventilation on inspiratory muscle activity in obese subjects. Eur Respir J. 1997;10(12):2847–52.
Pankow W, Podszus T, Gutheil T, Penzel T, Peter J, Von Wichert P. Expiratory flow limitation and intrinsic positive end-expiratory pressure in obesity. J Appl Physiol. 1998;85(4):1236–43.
Steier J, Jolley CJ, Seymour J, Roughton M, Polkey MI, Moxham J. Neural respiratory drive in obesity. Thorax. 2009;64(8):719–25.
Mokhlesi B, Kryger MH, Grunstein RR. Assessment and management of patients with obesity hypoventilation syndrome. Proc Am Thorac Soc. 2008;5(2):218–25.
Santana H, Zoico E, Turcato E, et al. Relation between body composition, fat distribution, and lung function in elderly men. Am J Clin Nutr. 2001;73(4):827–31.
Resta O, Foschino-Barbaro MP, Bonfitto P, et al. Prevalence and mechanisms of diurnal hypercapnia in a sample of morbidly obese subjects with obstructive sleep apnea. Respir Med. 2000;94:240–6.
Zavorsky GS, Hoffman SL. Pulmonary gas exchange in the morbidly obese. Obes Rev. 2008;9(4):326–39.
Heinemann F, Budweiser S, Dobroschke J, Pfeifer M. Non-invasive positive pressure ventilation improves lung volumes in the obesity hypoventilation syndrome. Respir Med. 2007;101(6):1229–35.
Ladosky W, Botelho MAM, Albuquerque JP. Chest mechanics in morbidly obese non-hypoventilated patients. Respir Med. 2001;95:281–6.
Sahebjami H, Gartside PS. Pulmonary function in obese subjects with a normal FEV1/FVC ratio. Chest. 1996;110(6):1425–9.
Weiner P, Waizman J, Weiner M, Rabner M, Magadle R, Zamir D. Influence of excessive weight loss after gastroplasty for morbid obesity on respiratory muscle performance. Thorax. 1998;53(1):39–42.
Farkas GA, Gosselin LE, Zhan WZ, Schlenker EH, Sieck GC. Histochemical and mechanical properties of diaphragm muscle in morbidly obese Zucker rats. J Appl Physiol. 1994;77(5):2250–9.
Powers SK, Farkas GA, Demirel H, et al. Effects of aging and obesity on respiratory muscle phenotype in Zucker rats. J Appl Physiol. 1996;81(3):1347–54.
Collet F, Mallart A, Bervar JF, et al. Physiologic correlates of dyspnea in patients with morbid obesity. Int J Obes. 2006;31(4):700–6.
Heinzer RC, Stanchina ML, Malhotra A, et al. Lung volume and continuous positive airway pressure requirements in obstructive sleep apnea. Am J Respir Crit Care Med. 2005;172(1):114–7.
Series F, Cormier Y, Desmeules M. Influence of passive changes of lung volume on upper airways. J Appl Physiol. 1990;68(5):2159–64.
Heinzer RC, Stanchina ML, Malhotra A, et al. Effect of increased lung volume on sleep disordered breathing in patients with sleep apnoea. Thorax. 2006;61(5):435–9.
Gilbert R, Sipple JH, Auchincloss JH Jr. Respiratory control and work of breathing in obese subjects. J Appl Physiol. 1961;16:21–6.
Kress JP, Pohlman AS, Alverdy J, Hall JB. The impact of morbid obesity on oxygen cost of breathing (VO(2RESP)) at rest. Am J Respir Crit Care Med. 1999;160(3):883–6.
Lin CC. Effect of nasal CPAP on ventilatory drive in normocapnic and hypercapnic patients with obstructive sleep apnoea syndrome. Eur Respir J. 1994;7(11):2005–10.
Lopata M, Onal E. Mass loading, sleep apnea, and the pathogenesis of obesity hypoventilation. Am Rev Respir Dis. 1982;126(4):640–5.
Sampson MG, Grassino K. Neuromechanical properties in obese patients during carbon dioxide rebreathing. Am J Med. 1983;75(1):81–90.
Berger KI, Ayappa I, Chatr-Amontri B, et al. Obesity hypoventilation syndrome as a spectrum of respiratory disturbances during sleep. Chest. 2001;120(4):1231–8.
Chouri-Pontarollo N, Borel JC, Tamisier R, Wuyam B, Levy P, Pepin JL. Impaired objective daytime vigilance in obesity-hypoventilation syndrome: impact of noninvasive ventilation. Chest. 2007;131(1):148–55.
Lopata M, Freilich RA, Onal E, Pearle J, Lourenco RV. Ventilatory control and the obesity hypoventilation syndrome. Am Rev Respir Dis. 1979;119(2 Pt 2):165–8.
Zwillich CW, Sutton FD, Pierson DJ, Greagh EM, Weil JV. Decreased hypoxic ventilatory drive in the obesity-hypoventilation syndrome. Am J Med. 1975;59(3):343–8.
Tankersley C, Kleeberger S, Russ B, Schwartz A, Smith P. Modified control of breathing in genetically obese (ob/ob) mice. J Appl Physiol. 1996;81(2):716–23.
Javaheri S, Colangelo G, Corser B, Zahedpour MR. Familial respiratory chemosensitivity does not predict hypercapnia of patients with sleep apnea–hypopnea syndrome. Am Rev Respir Dis. 1992;145(4 Pt 1):837–40.
Jokic R, Zintel T, Sridhar G, Gallagher CG, Fitzpatrick MF. Ventilatory responses to hypercapnia and hypoxia in relatives of patients with the obesity hypoventilation syndrome. Thorax. 2000;55(11):940–5.
Sugerman HJ, Fairman RP, Sood RK, Engle K, Wolfe L, Kellum JM. Long-term effects of gastric surgery for treating respiratory insufficiency of obesity. Am J Clin Nutr. 1992;55(2 Suppl):597 S-601 S.
El-Gamal H, Khayat A, Shikora S, Unterborn JN. Relationship of dyspnea to respiratory drive and pulmonary function tests in obese patients before and after weight loss. Chest. 2005;128(6):3870–4.
Han F, Chen E, Wei H, He Q, Ding D, Strohl KP. Treatment effects on carbon dioxide retention in patients with obstructive sleep apnea–hypopnea syndrome. Chest. 2001;119(6):1814–9.
Mokhlesi B. Obesity hypoventilation syndrome: a state-of-the-art review. Respir Care. 2010;55(10):1347–62. Discussion 1363–1345.
Friedman J. The function of leptin in nutrition, weight and physiology. Nutr Rev. 2002;60:S1–14.
Kalra SP. Central leptin insufficiency syndrome: an interactive etiology for obesity, metabolic and neural diseases and for designing new therapeutic interventions. Peptides. 2008;29(1):127–38.
Chang Z, Ballou E, Jiao W, McKenna KE, Morrison SF, McCrimmon DR. Systemic leptin produces a long-lasting increase in respiratory motor output in rats. Front Physiol. 2013;4:16.
Phipps PR, Starritt E, Caterson I, Grunstein RR. Association of serum leptin with hypoventilation in human obesity. Thorax. 2002;57(1):75–6.
Campo A, Fruhbeck G, Zulueta JJ, et al. Hyperleptinemia, respiratory drive and hypercapnic response in obese patients. Eur Respir J. 2007;30:223–31.
O’Donnell CP, Schaub CD, Haines AS, et al. Leptin prevents respiratory depression in obesity. Am J Respir Crit Care Med. 1999;159(5 Pt 1):1477–84.
Shimura R, Tatsumi K, Nakamura A, et al. Fat accumulation, leptin, and hypercapnia in obstructive sleep apnea–hypopnea syndrome. Chest. 2005;127(2):543–9.
Makinodan K, Yoshikawa M, Fukuoka A, et al. Effect of serum leptin levels on hypercapnic ventilatory response in obstructive sleep apnea. Respiration. 2008;75(3):257–64.
Polotsky M, Elsayed-Ahmed AS, Pichard L, et al. Effects of leptin and obesity on the upper airway function. J Appl Physiol. 2012;112(10):1637–43.
Ozturk L, Unal M, Tamer L, Celikoglu F. The association of the severity of obstructive sleep apnea with plasma leptin levels. Arch Otolaryngol Head Neck Surg. 2003;129(5):538–40.
Chin K, Ohi M, Kita H, et al. Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 1996;153(6 Pt 1):1972–6.
Yee BJ, Cheung J, Phipps P, Banerjee D, Piper AJ, Grunstein RR. Treatment of obesity hypoventilation syndrome and serum leptin. Respiration. 2006;73(2):209–12.
Grunstein RR, Ho KY, Berthon-Jones M, Stewart D, Sullivan CE. Central sleep apnea is associated with increased ventilatory response to carbon dioxide and hypersecretion of growth hormone in patients with acromegaly. Am J Respir Crit Care Med. 1994;150(2):496–502.
Lindgren AC, Hellstrom LG, Ritzen EM, Milerad J. Growth hormone treatment increases CO(2) response, ventilation and central inspiratory drive in children with Prader–Willi syndrome. Eur J Pediatr. 1999;158(11):936–40.
Monneret D, Borel JC, Pepin JL, et al. Pleiotropic role of IGF-I in obesity hypoventilation syndrome. Growth Horm IGF Res. 2010;20(2):127–33.
Piper AJ, Grunstein RR. Obesity hypoventilation syndrome: mechanisms and management. Am J Respir Crit Care Med. 2011;183(3):292–8.
Perez de Llano LA, Golpe R, Ortiz Piquer M, et al. Short-term and long-term effects of nasal intermittent positive pressure ventilation in patients with obesity-hypoventilation syndrome. Chest. 2005;128(2):587–94.
Piper AJ, Wang D, Yee BJ, Barnes DJ, Grunstein RR. Randomised trial of CPAP vs bilevel support in the treatment of obesity hypoventilation syndrome without severe nocturnal desaturation. Thorax. 2008;63(5):395–401.
Berger KI, Goldring RM, Rapoport DM. Obesity hypoventilation syndrome. Semin Respir Crit Care Med. 2009;30:253–61.
Ayappa I, Berger KI, Norman RG, Oppenheimer BW, Rapoport DM, Goldring RM. Hypercapnia and ventilatory periodicity in obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 2002;166(8):1112–5.
Berger KI, Ayappa I, Sorkin IB, Norman RG, Rapoport DM, Goldring RM. CO(2) homeostasis during periodic breathing in obstructive sleep apnea. J Appl Physiol. 2000;88(1):257–64.
Berger KI, Ayappa I, Sorkin IB, Norman RG, Rapoport DM, Goldring RM. Postevent ventilation as a function of CO(2) load during respiratory events in obstructive sleep apnea. J Appl Physiol. 2002;93(3):917–24.
Norman RG, Goldring RM, Clain JM, et al. Transition from acute to chronic hypercapnia in patients with periodic breathing: predictions from a computer model. J Appl Physiol. 2006;100(5):1733–41.
Chin K, Hirai M, Kuriyama T, et al. Changes in the arterial PCO2 during a single night’s sleep in patients with obstructive sleep apnea. Intern Med. 1997;36(7):454–60.
Raurich JM, Rialp G, Ibanez J, Llompart-Pou JA, Ayestaran I. Hypercapnic respiratory failure in obesity-hypoventilation syndrome: co response and acetazolamide treatment effects. Respir Care. 2010;55(11):1442–8.
Hlavac MC, Catcheside PG, McDonald R, Eckert DJ, Windler S, McEvoy RD. Hypoxia impairs the arousal response to external resistive loading and airway occlusion during sleep. Sleep. 2006;29(5):624–31.
Lee S-D, Nakano H, Farkas GA. Adenosinergic modulation of ventilation in obese zucker rats. Obes Res. 2005;13(3):545–55.
Yang AL, Lo MJ, Ting H, Chen JS, Huang CY, Lee SD. GABA(A) and GABA(B) receptors differentially modulate volume and frequency in ventilatory compensation in obese Zucker rats. J Appl Physiol. 2007;102(1):350–7.
Piper A, Sullivan C. Effects of short-term NIPPV in the treatment of patients with severe obstructive sleep apnea and hypercapnia. Chest. 1994;105(2):434–40.
Banerjee D, Yee BJ, Piper AJ, Zwillich CW, Grunstein RR. Obesity hypoventilation syndrome: hypoxemia during continuous positive airway pressure. Chest. 2007;131(6):1678–84.
Sullivan CE, Berthon-Jones M, Issa FG. Remission of severe obesity-hypoventilation syndrome after short-term treatment during sleep with nasal continuous positive airway pressure. Am Rev Respir Dis. 1983;128(1):177–81.
Hida W, Okabe S, Tatsumi K, et al. Nasal continuous positive airway pressure improves quality of life in obesity hypoventilation syndrome. Sleep Breath. 2003;7(1):3–12.
Mokhlesi B, Tulaimat A, Evans AT, et al. Impact of adherence with positive airway pressure therapy on hypercapnia in obstructive sleep apnea. J Clin Sleep Med. 2006;2(1):57–62.
De Miguel DJ, De Lucas RP, Perez Parra JJ, Buendia Garcia MJ, Cubillo Marcos JM, Gonzalez-Moro JM. Analysis of withdrawal from noninvasive mechanical ventilation in patients with obesity-hypoventilation syndrome. Medium term results. Arch Bronconeumol. 2003;39(7):292–7.
Kushida CA, Littner MR, Hirshkowitz M, et al. Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders. Sleep. 2006;29(3):375–80.
Borel JC, Tamisier R, Gonzalez-Bermejo J, et al. Noninvasive ventilation in mild obesity hypoventilation syndrome: a randomized controlled trial. Chest. 2012;141(3):692–702.
Ambrogio C, Lowman X, Kuo M, Malo J, Prasad A, Parthasarathy S. Sleep and non-invasive ventilation in patients with chronic respiratory failure. Intensive Care Med. 2009;35:306–13.
Janssens JP, Metzger M, Sforza E. Impact of volume targeting on efficacy of bi-level non-invasive ventilation and sleep in obesity-hypoventilation. Respir Med. 2009;103(2):165–72.
Murphy PB, Davidson C, Hind MD, et al. Volume targeted versus pressure support non-invasive ventilation in patients with super obesity and chronic respiratory failure: a randomised controlled trial. Thorax. 2012;67(8):727–34.
Storre JH, Bohm P, Dreher M, Windisch W. Clinical impact of leak compensation during non-invasive ventilation. Respir Med. 2009;103(10):1477–83.
British Thoracic Society Standards of Care Committee. Non-invasive ventilation in acute respiratory failure. Thorax. 2002;57(3):192–211.
Redolfi S, Corda L, Piana G L, Spandrio S, Prometti P, Tantucci C. Long-term non-invasive ventilation increases chemosensitivity and leptin in obesity-hypoventilation syndrome. Respir Med. 2007;101(6):1191–5.
Kushida CA, Chediak A, Berry RB, et al. Clinical guidelines for the manual titration of positive airway pressure in patients with obstructive sleep apnea. J Clin Sleep Med. 2008;4(2):157–71.
Piper A. Obesity hypoventilation syndrome: therapeutic implications for treatment. Expert Rev Resp Med. 2010;4(1):57–70.
Berry RB, Chediak A, Brown LK, et al. Best clinical practices for the sleep center adjustment of noninvasive positive pressure ventilation (NPPV) in stable chronic alveolar hypoventilation syndromes. J Clin Sleep Med. 2010;6(5):491–509.
Janssens JP, Borel JC, Pepin JL. Nocturnal monitoring of home non-invasive ventilation: the contribution of simple tools such as pulse oximetry, capnography, built-in ventilator software and autonomic markers of sleep fragmentation. Thorax. 2011;66(5):438–45.
Maniscalco M, Zedda A, Faraone S, Carratu P, Sofia M. Evaluation of a transcutaneous carbon dioxide monitor in severe obesity. Intensive Care Med. 2008;34(7):1340–4.
Morgenthaler TI, Aurora N, Brown T, et al. Practice parameters for the use of autotitrating continuous positive airway pressure devices for titrating pressures and treating adult patients with obstructive sleep apnea syndrome: an update for 2007. Sleep. 2008;31(1):141–7.
Krieger J, Weitzenblum E, Monassier JP, Stoeckel C, Kurtz D. Dangerous hypoxaemia during continuous positive airway pressure treatment of obstructive sleep apnoea. Lancet. 1983;2(8364):1429–30.
Guo YF, Sforza E, Janssens JP. Respiratory patterns during sleep in obesity-hypoventilation patients treated with nocturnal pressure support: a preliminary report. Chest. 2007;131(4):1090–9.
Contal O, Adler D, Borel JC, et al. Impact of different back-up respiratory rates on the efficacy of non-invasive positive pressure ventilation in obesity hypoventilation syndrome: a randomized trial. Chest. 2013;143(1):37–46.
Fanfulla F, Taurino AE, Lupo ND, Trentin R, D’Ambrosio C, Nava S. Effect of sleep on patient/ventilator asynchrony in patients undergoing chronic non-invasive mechanical ventilation. Respir Med. 2007;101(8):1702–7.
Gonzalez-Bermejo J, Perrin C, Janssens JP, et al. Proposal for a systematic analysis of polygraphy or polysomnography for identifying and scoring abnormal events occurring during non-invasive ventilation. Thorax. 2012;67(6):546–52.
Brown LKMDF. Noninvasive ventilatory support in obesity hypoventilation syndrome: backup early and often? Chest. 2013;143(1):8–10.
Windisch W, Storre JH. Target volume settings for home mechanical ventilation: great progress or just a gadget? Thorax. 2012;67(8):663–5.
de Lucas-Ramos P, de Miguel-Díez J, Santacruz-Siminiani A, González-Moro JMR, Buendía-García MJ, Izquierdo-Alonso JL. Benefits at 1 year of nocturnal intermittent positive pressure ventilation in patients with obesity-hypoventilation syndrome. Respir Med. 2004;98(10):961–7.
Storre JH, Seuthe B, Fiechter R, et al. Average volume-assured pressure support in obesity hypoventilation: a randomized crossover trial. Chest. 2006;130(3):815–21.
Masa JF, Celli BR, Riesco JA, Sanchez de Cos J, Disdier C, Sojo A. Noninvasive positive pressure ventilation and not oxygen may prevent overt ventilatory failure in patients with chest wall diseases. Chest. 1997;112(1):207–13.
Wijesinghe M, Williams M, Perrin K, Weatherall M, Beasley R. The effect of supplemental oxygen on hypercapnia in subjects with obesity-associated hypoventilation: a randomized, crossover, clinical study. Chest. 2011;139(5):1018–24.
Hollier CA, Harmer AR, Maxwell LJ, et al. Moderate concentrations of supplemental oxygen worsen hypercapnia in obesity hypoventilation syndrome: a randomised crossover study. Thorax. 2014;69(4):346–53.
Masa JF, Celli BR, Riesco JA, Hernandez M, Sanchez De Cos J, Disdier C. The obesity hypoventilation syndrome can be treated with noninvasive mechanical ventilation. Chest. 2001;119(4):1102–7.
Borel J-C, Burel B, Tamisier R, et al. Comorbidities and mortality in hypercapnic obese under domiciliary noninvasive ventilation. PLoS ONE. 2013;8(1):e52006.
Laub M, Midgren B. Survival of patients on home mechanical ventilation: a nationwide prospective study. Respir Med. 2007;101(6):1074–8.
Ram FS, Picot J, Lightowler J, Wedzicha JA. Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2004; Issue 3: Art. No.:CD004104. doi:004110.001002/14651858.CD14004104.pub14651853.
Pepin J-L, Borel J-C, Janssens J-P. Obesity hypoventilation syndrome: an underdiagnosed and undertreated condition. Am J Respir Crit Care Med. 2012;186(12):1205–7.
Castro-Anon O, Golpe R, Perez-De-Llano LA, et al. Haemodynamic effects of non-invasive ventilation in patients with obesity-hypoventilation syndrome. Respirology. 2012;17(8):1269–74.
Arias MA, Garcia-Rio F, Alonso-Fernandez A, Martinez I, Villamor J. Pulmonary hypertension in obstructive sleep apnoea: effects of continuous positive airway pressure: a randomized, controlled cross-over study. Eur Heart J. 2006;27(9):1106–13.
Kauppert CA, Dvorak I, Kollert F, et al. Pulmonary hypertension in obesity-hypoventilation syndrome. Respir Med. 2013;107(12):2061–70.
Borel J-C, Borel A-L, Monneret D, Tamisier R, Levy P, Pepin J-L. Obesity hypoventilation syndrome: from sleep-disordered breathing to systemic comorbidities and the need to offer combined treatment strategies. Respirology. 2012;17(4):601–10.
Campos-Rodriguez F, Martinez-Garcia MA, Reyes-Nuñez N, et al. Long-term CPAP compliance in females with obstructive sleep apnoea. Eur Respir J. 2013.
Sawyer AM, Gooneratne NS, Marcus CL, Ofer D, Richards KC, Weaver TE. A systematic review of CPAP adherence across age groups: clinical and empiric insights for developing CPAP adherence interventions. Sleep Med Rev. 2011;15(6):343–56.
Ye L, Pack AI, Maislin G, et al. Predictors of continuous positive airway pressure use during the first week of treatment. J Clin Sleep Med. 2012;21(4):419–26.
Bakker JP, Marshall NS. Flexible pressure delivery modification of continuous positive airway pressure for obstructive sleep apnea does not improve compliance with therapy: systematic review and meta-analysis. Chest. 2011;139(6):1322–30.
Richards D, Bartlett DJ, Wong K, Malouff J, Grunstein RR. Increased adherence to CPAP with a group cognitive behavioral treatment intervention: a randomized trial. Sleep. 2007;30(5):635–40.
Shapiro G, Shapiro C. Factors that influence CPAP adherence: an overview. Sleep Breath. 2010;14(4):323–35.
Boone KA, Cullen JJ, Mason EE, Scott DH, Doherty C, Maher JW. Impact of vertical banded gastroplasty on respiratory insufficiency of severe obesity. Obes Surg. 1996;6(6):454–8.
Davila-Cervantes A, Dominguez-Cherit G, Borunda D, et al. Impact of surgically-induced weight loss on respiratory function: a prospective analysis. Obes Surg. 2004;14:1389–92.
Sugerman HJ, Baron PL, Fairman RP, Evans CR, Vetrovec GW. Hemodynamic dysfunction in obesity hypoventilation syndrome and the effects of treatment with surgically induced weight loss. Ann Surg. 1988;207(5):604–13.
Sjostrom L, Lindroos A-K, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683–93.
Goodpaster BH, DeLany JP, Otto AD, et al. Effects of diet and physical activity interventions on weight loss and cardiometabolic risk factors in severely obese adults: a randomized trial. JAMA. 2010;304(16):1795–802.
Murphy PB, Polkey MI, Hart N. Obesity hypoventilation syndrome. The need for a multifaceted approach to treatment. Chest. 2012;142(2):540–1.
Borel JC, Tamisier R, Levy P, Pepin JL. Obesity hypoventilation syndrome. The need for a multifaceted approach to treatment. Response. Chest. 2012;142(2):541.
Jordan KE, Ali M, Shneerson JM. Attitudes of patients towards a hospital-based rehabilitation service for obesity hypoventilation syndrome. Thorax. 2009;64(11):1007–7.
Borel JC, Wuyam B, Chouri-Pontarollo N, Deschaux C, Levy P, Pepin JL. During exercise non-invasive ventilation in chronic restrictive respiratory failure. Respir Med. 2008;102(5):711–9.
Menadue C, Alison JA, Piper AJ, Flunt D, Ellis ER. Non-invasive ventilation during arm exercise and ground walking in patients with chronic hypercapnic respiratory failure. Respirology. 2009;14(2):251–9.
Dreher M, Kabitz HJ, Burgardt V, Walterspacher S, Windisch W. Proportional assist ventilation improves exercise capacity in patients with obesity. Respiration. 2010;80(2):106–11.
Villiot-Danger JC, Villiot-Danger E, Borel JC, Pepin JL, Wuyam B, Verges S. Respiratory muscle endurance training in obese patients. Int J Obes (Lond). 2011;35(5):692–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Piper, A., Hollier, C. (2015). Nocturnal Noninvasive Ventilation in Obesity Hypoventilation Syndrome. In: Basner, R., Parthasarathy, S. (eds) Nocturnal Non-Invasive Ventilation. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-7624-6_4
Download citation
DOI: https://doi.org/10.1007/978-1-4899-7624-6_4
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-7623-9
Online ISBN: 978-1-4899-7624-6
eBook Packages: MedicineMedicine (R0)